Patient age, average 6MP behavioral adherence, 6MP absolute metabolite levels, duration of cancer diagnosis and maintenance therapy, patient gender, patient ethnicity/race, household composition (one- vs. two-parent households), annual household income, medication administration patterns, 6MP dose recommendations, and thiopurine methyltransferase (TPMT) activity will be evaluated. This evidence concerns the gene TPMT and cancer.